AngioDynamics, Inc.  

(Public, NASDAQ:ANGO)   Watch this stock  
Find more results for ango
16.74
+0.12 (0.72%)
After Hours: 16.74 0.00 (0.00%)
Dec 7, 4:50PM EST  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 16.33 - 16.79
52 week 9.71 - 17.64
Open 16.62
Vol / Avg. 240,750.00/358,670.00
Mkt cap 628.99M
P/E     -
Div/yield     -
EPS -1.14
Shares 37.14M
Beta 0.92
Inst. own 96%
Jan 5, 2017
Q2 2017 AngioDynamics Inc Earnings Release (Estimated) - 9:30AM EST - Add to calendar
Nov 30, 2016
AngioDynamics Inc at Evercore ISI MedTools Conference
Nov 29, 2016
AngioDynamics Inc at Piper Jaffray Healthcare Conference
Nov 17, 2016
AngioDynamics Inc at Canaccord Genuity Med Tech Conference
Oct 26, 2016
AngioDynamics Inc Annual Shareholders Meeting (Estimated)
Oct 25, 2016
AngioDynamics Inc Annual Shareholders Meeting
Oct 5, 2016
Q1 2017 AngioDynamics Inc Earnings Release
Oct 5, 2016
Q1 2017 AngioDynamics Inc Earnings Call - Webcast
Sep 13, 2016
AngioDynamics Inc at Morgan Stanley Global Healthcare Conference - Webcast
More events from DailyFinance »    

Key stats and ratios

Q3 (Aug '16) 2016
Net profit margin 1.48% -12.32%
Operating margin 4.05% 0.29%
EBITD margin - 12.06%
Return on average assets 0.72% -5.81%
Return on average equity 1.02% -8.28%
Employees 1,300 -
CDP Score - -

Address

14 Plaza Dr
LATHAM, NY 12110-2166
United States - Map
+1-518-7981215 (Phone)
+1-518-7951401 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

AngioDynamics, Inc. designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company's devices are used in minimally invasive, image-guided procedures. The Company offers products within three product groupings: Peripheral Vascular, Vascular Access and Oncology/Surgery. The Company's Peripheral Vascular products include Fluid Management, Venous, Thrombus Management, as well as other core products. The Company's BioFlo products incorporate Endexo Technology into the manufacturing and design of its Vascular Access products. Its Oncology/Surgery product offerings include its Microwave Ablation products, Radiofrequency Ablation (RFA) and its NanoKnife product lines.

Officers and directors

Howard W. Donnelly Independent Chairman of the Board
Age: 54
Bio & Compensation  - Reuters
James C. Clemmer President, Chief Executive Officer, Director
Age: 51
Bio & Compensation  - Reuters
Michael Greiner Chief Financial Officer, Executive Vice President
Age: 43
Bio & Compensation  - Reuters
Gary Barrett Senior Vice President,Quality and Regulatory Affairs
Age: 47
Bio & Compensation  - Reuters
Ben Davis Senior Vice President, Business Development
Age: 51
Bio & Compensation  - Reuters
Barbara Kucharczyk Senior Vice President-Global Operations
Age: 42
Bio & Compensation  - Reuters
Stephen A. Trowbridge Senior Vice President, General Counsel
Age: 41
Bio & Compensation  - Reuters
Eileen O'Shea Auen Director
Age: 53
Bio & Compensation  - Reuters
Jan Stern Reed Director
Age: 55
Bio & Compensation  - Reuters
David F. Burgstahler Independent Director
Age: 48
Bio & Compensation  - Reuters